Jpmorgan Chase & Co. - Net Worth and Insider Trading
Jpmorgan Chase & Co. Net Worth
The estimated net worth of Jpmorgan Chase & Co. is at least $141 Million dollars as of 2024-06-24. Jpmorgan Chase & Co. is the of CanSino Biologics Inc and owns about 7,010,849 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $141 Million. Details can be seen in Jpmorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jpmorgan Chase & Co. has not made any transactions after 2023-07-25 and currently still holds the listed stock(s).
Transaction Summary of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jpmorgan Chase & Co. owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Click here to see the complete history of Jpmorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of Jpmorgan Chase & Co.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:06185 | CanSino Biologics Inc | 2023-07-25 |
Jpmorgan Chase & Co. Latest Holdings Summary
Jpmorgan Chase & Co. currently owns a total of 1 stock. Jpmorgan Chase & Co. owns 7,010,849 shares of CanSino Biologics Inc (HKSE:06185) as of July 25, 2023, with a value of $141 Million.
Latest Holdings of Jpmorgan Chase & Co.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:06185 | CanSino Biologics Inc | 2023-07-25 | 7,010,849 | 20.10 | 140,918,065 |
Holding Weightings of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, Jpmorgan Chase & Co. has made a total of 122 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 10 buys and 11 sells. The most-recent trade in CanSino Biologics Inc is the sale of 0 shares on July 25, 2023, which brought Jpmorgan Chase & Co. around $0.
Insider Trading History of Jpmorgan Chase & Co.
- 1
Jpmorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of Jpmorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jpmorgan Chase & Co. is -24.58%. GuruFocus also compares Jpmorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Jpmorgan Chase & Co. within 3 months outperforms 1 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jpmorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of Jpmorgan Chase & Co.
Jpmorgan Chase & Co. Ownership Network
Ownership Network List of Jpmorgan Chase & Co.
Ownership Network Relation of Jpmorgan Chase & Co.
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Jpmorgan Chase & Co. Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
Jpmorgan Chase & Co. is the of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. , Citigroup Inc. , and 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, Jpmorgan Chase & Co. made 68 insider transaction in CanSino Biologics Inc (HKSE:06185) with a net sale of 1,501,555. Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net sale of 0 shares made by Citigroup Inc. , a net sale of 7,656,500 shares made by The Capital Group Companies, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,934,340 shares of CanSino Biologics Inc (HKSE:06185) were sold and 2,776,285 shares were bought by its insiders, resulting in a net sale of 9,158,055 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
Jpmorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for Jpmorgan Chase & Co.. Currently GuruFocus does not have mailing address information for Jpmorgan Chase & Co..